ABCA1 and chronic kidney disease: According to previously published results in chronic kidney disease patients, such inflammatory mediators as lipopolysaccharide and cytokines inhibit cholesterol efflux from cells by decreasing expression of the adenosine triphosphate–binding cassette A1 (ABCA1) gene.